Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001
0.76%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$66.37
Buy:$66.39
Change:
$0.31
(0.46%)
$0.31
(0.46%)Market closed |
Prices delayed by at least 15 minutes
Sell:$66.37
Buy:$66.39
Change:$0.31
(0.46%)
$0.31
(0.46%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 29 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Option/Award related | 35,181 | $69.33 | $2,439,098.73 | 3,822,471 |
| 29 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Option/Award related | 16,545 | $68.69 | $1,136,476.05 | 3,805,926 |
| 26 December 2025 | Mauro FerrariIndependent Director | Sell Regular sell transaction (market) | 7,530 | $70.00 | $527,100.00 | 69,053 |
| 22 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Regular sell transaction (market) | 10,012 | $68.33 | $684,119.96 | 3,808,500 |
| 22 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Regular sell transaction (market) | 2,574 | $68.85 | $177,219.90 | 3,805,926 |
| 19 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Regular sell transaction (market) | 3,979 | $66.67 | $265,279.93 | 3,827,978 |
| 19 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Regular sell transaction (market) | 8,147 | $68.01 | $554,077.47 | 3,819,831 |
| 19 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Regular sell transaction (market) | 1,319 | $68.48 | $90,325.12 | 3,818,512 |
| 19 December 2025 | William D WaddillIndependent Director | Sell Regular sell transaction (market) | 2,416 | $66.66 | $161,050.56 | 62,514 |
| 19 December 2025 | William D WaddillIndependent Director | Sell Regular sell transaction (market) | 5,451 | $68.01 | $370,722.51 | 57,063 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Tax related | 100,532 | $68.67 | $6,903,532.44 | 4,000,723 |
| 3 March 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Option/Award related | 166,667 | $18.03 | $3,005,006.01 | 3,907,135 |
| 17 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Tax related | 46,287 | $63.55 | $2,941,538.85 | 3,870,670 |
| 29 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Option/Award related | 35,181 | $69.33 | $2,439,098.73 | 3,822,471 |
| 17 December 2025 | Christopher Richard AnzaloneChairman/CEO | Sell Tax related | 35,750 | $64.51 | $2,306,232.50 | 3,834,920 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.